| Product Information |
BR-1346_PI_01.pdf
|
| Registration Number |
BR-1346
|
| Generic Name |
Semaglutide
|
| Brand Name |
Ozempic
|
| Dosage Strength |
0.25 mg/0.19 mL (1.34 mg/mL)
|
| Dosage Form |
Solution for Injection (SC)
|
| Classification |
Prescription Drug (RX)
|
| Pharmacologic Category |
Glucagon-like peptide (GLP-1) Analogues
|
| Packaging |
Multiple dose. 1.5 mL Type I glass cartridge with chlorobutyl rubber plunger and aluminum cap with a laminated rubber sheet assembled in blue PDS290 pen injector + 6 Novofine Plus 32G 4 mm needles (Box of 1's)
|
| Manufacturer |
Novo Nordisk A/S
|
| Country of Origin |
Denmark
|
| Trader |
N/A
|
| Importer |
Novo Nordisk Pharmaceuticals (Philippines), Inc.
|
| Distributor |
Novo Nordisk Pharmaceuticals (Philippines), Inc.
|
| Application Type |
Monitored Release (Variation)
|
| Issuance Date |
28 October 2022
|
| Expiry Date |
28 October 2027
|